Affordable cancer drug shows promise in lab tests

NCT ID NCT04234022

Recruiting now Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a drug called Imuthiol (Zn-DDC) can kill cancer cells, especially cancer stem cells, in the lab. Researchers will test the drug on bone marrow samples donated by 70 patients with blood cancers like multiple myeloma and acute leukemia. The goal is to gather information to see if this affordable drug should be tested in future treatment trials, either alone or combined with other medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Royal Wolverhampton NHS Trust
RECRUITING

Wolverhampton, WV10 0QP, United Kingdom

Contact Email: •••••@•••••

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA